Cutaneous Carcinosarcoma Katy H. Goldsborough, William B. Laskin, Jeffrey D. Wayne, Mark Agulnik...

Post on 17-Jan-2018

221 views 0 download

description

Case Report 62 y.o. male Subcutaneous 4 mm nodule lateral to sternum Slow growth over 18 months Excisional bx followed by wide local excision p63AE1/ AE3 Cam 5.2 CK 5/6 BetaE12/ CK903 MNF116VimentinS100 BCC Sarcoma

Transcript of Cutaneous Carcinosarcoma Katy H. Goldsborough, William B. Laskin, Jeffrey D. Wayne, Mark Agulnik...

Cutaneous Carcinosarcoma

Katy H. Goldsborough, William B. Laskin, Jeffrey D. Wayne, Mark Agulnik

Department of Medicine, Division of Hematology/ Oncology,Department of Pathology

Department of Surgery, Division of Surgical Oncology

Feinberg School of Medicine,Northwestern University,

Chicago, IL

Carcinosarcomas (CS): Background

• Malignant neoplasm– Biphasic epithelial and mesenchymal

elements– Breast, lung, urogenital, gastrointestinal– Hypothesis- Multiclonal vs. Monoclonal– IHC studies establish 2 distinct populations

• Primary cutaneous CS– Dawson 1972– Basal and squamous cell carcinoma– Pleomorphic/ atypical fibroxanthoma/ MFH

Case Report

• 62 y.o. male• Subcutaneous 4 mm nodule lateral to sternum• Slow growth over 18 months• Excisional bx followed by wide local excision

p63 AE1/AE3

Cam 5.2

CK 5/6

BetaE12/CK903

MNF116 Vimentin S100

BCC + + + + + + - -

Sarcoma - - - - - - + -

Methods

• All case reports and series of CCS• Search terms:

» Carcinosarcoma» Carcinoma and sarcoma» Sarcomatous sarcoma» Biphasic sarcomatoid carcinoma» Spindle cell carcinoma

• 48 publications reviewed

Results• Between 1972 and 2007: 74 cases of CCS have

been reported.Sex- M:F 49:25

Age Range (Mean) 36-93 (71)

Duration< 3 months3-6 months

> 6 -12 months1-2 years> 2 years

NR/UK

6 weeks- 50 yrs10655

2226

Size< 1 cm1-5 cm

>5-10 cm> 10 cmNR/ UK

9421346

EpithelialBCCSCC

SpiroadenocarcinomaPilar Tumor

Pilomatrix CarcinomaPorocarcinoma

Adenocarcinoma

3720116113

MesenchymalAngiosarcoma

ChondrosarcomaFibrosarcoma

LeiomyosarcomaOsteosarcoma

PleomorphicRhabdomyosarcomaSpindle cell Sarcoma

1715

24324

12

ResultsTreatment Surgery 74

Radiation 10

Chemotherapy 2

Survival AWOD<6 months

6-12 months>12 months

384

1321

DWOD< 12 months>12 months

716

AWD< 12 months> 12 months

532

DWD< 12 months> 12 months

1192

Unknown 13

Conclusions

• Primary CCS is a rare disease.• 6th-8th decade of life• Survival predicted by:

– Epithelial component– Growth pattern– Tumor size– Duration– LN involvement– Age

Conclusions

• Treatment approach– Wide local excision– Negative margins

• No defined role for adjuvant radiation therapy or chemotherapy.